Metabolomics, the study of metabolism has the capacity to convert our understanding of mechanisms of drug movement and the molecular foundation for variation in drug response. It is now possible to define metabolic signatures of drug publicity which can discover pathways concerned in both drug efficacy and adverse drug reactions. In addition, the metabotype, the metabolic signature of an affected person, is a completely unique identifier that includes records approximately drug reaction and disorder heterogeneity. The software of metabolomics for the examination of drug consequences and variant in drug reaction is developing pharmacometabolomics, a subject to contribute to customized drug remedy and will supplement pharmacogenomics with the aid of shooting environmental and microbiome-level impacts on response to drug remedy.

  • Track 1-1 Precision medicine
  • Track 2-2 Alterations in metabolic pathway
  • Track 3-3 Biomarker
  • Track 4-4 Applications in Clinical studies

Related Conference of Medical